Impact of antenatal corticosteroid therapy in very low birth weight infante on chronic lung disease and other morbidities of prematurity

Journal of Perinatology

Volumn 19, Issue 8 PART. 1, 1999, Pages 578-581

  Wells, Lorraine R ^a   Papile, Lu Ann ^a   Gardner, Michael O ^b   Hartenberger, Carol R ^a   Merker, Lisa ^a  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE; GLUCOCORTICOID;

ADULT; ARTICLE; CHRONIC DISEASE; FEMALE; FETUS MATURITY; HUMAN; LUNG; LUNG DISEASE; MALE; MORBIDITY; MORTALITY; NEWBORN; PREGNANCY; PREMATURITY; PRENATAL DEVELOPMENT; PROSPECTIVE STUDY; VERY LOW BIRTH WEIGHT;

ADULT; BETAMETHASONE; CHRONIC DISEASE; FEMALE; FETAL ORGAN MATURITY; GLUCOCORTICOIDS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; INFANT, VERY LOW BIRTH WEIGHT; LUNG; LUNG DISEASES; MALE; MORBIDITY; PREGNANCY; PROSPECTIVE STUDIES;

EID: 0033286204     PISSN: 07438346     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jp.7200268     Document Type: Article

References (14)

1. Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of respiratory distress syndrome in premature infants. Pediatrics 1972;50:526-34.
2. Report of the Consensus Development Conference on Effects of Corticosteroids for Fetal Maturation on Perinatal Outcomes. Bethesda, MD: Office of Medical Applications of Research. National Institutes of Health; 1994.
3. Wright L, Merenstein G, Goldenberg RL, Clever SP, Rowe M. Impact of the National Institutes of Health Consensus Development Conference on corticosteroids for fetal maturation: changes in obstetric attitudes. Pediatr Res 1996;39:254A.
4. Padbury JF, Ervin MG, Polk DH. Extrapulmonary effects of antenatally administered steroids. J Pediatr 1996;128:167-72.
5. Fanoroff AA, Wright LL, Stevenson DK, et al. Very-low birthweight outcomes of the National Institute of Child Health and Human Development Research Network, May 1991 through December 1992. Am J Ohstet Gynecol 1995;173:1423-31.
6. Bell MJ, Temberg JL, Feigin RD. Neonatal necrotizing enterocolitis: therapeutic decisions based on clinical staging. Ann Surg 1978;187:1-7.
7. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr 1978;92:529-34.
8. Gardner M, Goldenberg R, Gaudier F, Dubard M, Nelson K, Hauth J. Predicting low Apgar scores of infants weighing less than 1000 grams: the effect of corticosteroids. Obstet Gynecol 1995;85:170-4.
9. van de Bor M, Verloove-Vanhorick SP, Brand R, Keirse M, Ruys JH. Incidence and prediction of periventricular intraventricular hemorrhage in very preterm infants. J Perinat Med 1987;15:333-9.
10. Nelson KB, Grether JK. Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants? Pediatrics 1995;95:263-9.
11. Ment LR, Oh W, Ehrenkranz RA, et al. Low-dose indomethacin and prevention of intraventricular hemorrhage: a multicentered randomized trial. Pediatrics 1994; 93:543-50.
12. Lemons JA, Stevenson DK, Poole K, et al. In utero magnesium exposure: effects on extremely low birth weight (ELBW) infants. Pediatr Res 1999;45:1212A.
13. Norton ME, Merrill J, Cooper BAB, Kuller JA, Clyman RI. Neonatal complications after the administration of indomethacin for preterm labor. N Engl J Med 1993; 329:1602-7.
14. Kari M, Hallman M, Eronen M, et al. Prenatal dexamethasone treatment in conjunction with rescue therapy of human surfactant a randomized, placebo-controlled, multicenter study. Pediatrics 1994;93:730-6.